高级检索
张小鸿, 黄枝妙, 朱颖, 袁平. miR-135b对结肠癌细胞凋亡诱导作用及机制[J]. 中国公共卫生, 2022, 38(6): 783-786. DOI: 10.11847/zgggws1134110
引用本文: 张小鸿, 黄枝妙, 朱颖, 袁平. miR-135b对结肠癌细胞凋亡诱导作用及机制[J]. 中国公共卫生, 2022, 38(6): 783-786. DOI: 10.11847/zgggws1134110
ZHANG Xiao-hong, HUANG Zhi-miao, ZHU Ying, . Effect and mechanism of miR-135b on apoptosis of HCT116 colon cancer cells[J]. Chinese Journal of Public Health, 2022, 38(6): 783-786. DOI: 10.11847/zgggws1134110
Citation: ZHANG Xiao-hong, HUANG Zhi-miao, ZHU Ying, . Effect and mechanism of miR-135b on apoptosis of HCT116 colon cancer cells[J]. Chinese Journal of Public Health, 2022, 38(6): 783-786. DOI: 10.11847/zgggws1134110

miR-135b对结肠癌细胞凋亡诱导作用及机制

Effect and mechanism of miR-135b on apoptosis of HCT116 colon cancer cells

  • 摘要:
      目的  探讨miR-135b对HCT116结肠癌细胞凋亡的诱导作用及机制。
      方法  HCT116细胞分为对照组、miR-135b NC组及miR-135b inhibitor组,噻唑蓝(MTT)法检测细胞活力,Hoechst检测细胞凋亡,Western blot法检测B淋巴细胞瘤 – 2基因(Bcl-2)、Bcl-2相关蛋白X(Bax)、多聚ADP核糖多聚酶(cleaved-PARP)、含半胱氨酸的天冬氨酸蛋白水解酶(cleaved-caspase 3)、人第 10 号染色体缺失的磷酸酶及张力蛋白同源基因(PTEN)、磷脂酰肌醇 3 – 激酶(PI3K)、蛋白激酶A(AKT)表达。
      结果  与对照组(1.00 ± 0.03)及miR-135b NC组(1.02 ± 0.04)比较,miR-135b inhibitor组细胞中miR-135b表达(0.53 ± 0.05)显著下调(F = 259.19,P < 0.05)。对照组、miR-135b NC组、miR-135b inhibitor组HCT116细胞活力和细胞凋亡率分别为(0.58 ± 0.05)、(0.59 ± 0.06)、(0.39 ± 0.04)和(3.24 ± 0.13)%、(3.27 ± 0.08)%、(36.48 ± 0.52)%,与对照组、miR-135b NC组比较,miR-135b inhibitor组HCT116细胞活力明显下降(P < 0.05),凋亡率显著升高(P < 0.05)。与对照组、miR-135b NC组比较,miR-135b inhibitor组HCT116细胞Bcl-2、cleaved-caspsase 3、PI3K及p-AKT蛋白表达下调(P < 0.05),Bax、cleaved-PARP及PTEN蛋白表达明显上调(P < 0.05)。
      结论  下调miR-135b可诱导HCT116细胞凋亡,其机制可能与阻断PTEN/PI3K/AKT信号通路有关。

     

    Abstract:
      Objective  To explore the effect and mechanism of microRNA-135b (miR-135b) on apoptosis of HCT116 colon cancer cells.
      Methods   HCT116 cells were divided into control group, miR-135b NC group and miR-135b inhibitor group. Cell viability was detected with 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Cell apoptosis was detected with Hoechst staining. The expression of B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X (Bax), poly ADP-ribose polymerase (cleaved-PARP), cysteinyl aspartate specific proteinase (cleaved-caspase 3), phosphatase and tensin homolog deleted on chromosome ten (PTEN), phosphatidylinositol 3-kinase (PI3K), and protein kinase A (AKT) were detected with Western blot.
      Results  The expression of miR-135b was down-regulated in miR-135b inhibitor group compared with that in control group and miR-135b NC group (0.53 ± 0.05 vs. 1.00 ± 0.03 and 1.02 ± 0.04) (F = 259.19, P < 0.05). The cell viability and apoptotic rate of HCT116 cells were 0.58 ± 0.05 and 3.24 ± 0.13% for control group, 0.59 ± 0.06 and 3.27 ± 0.08% for miR-135b NC group, and 0.39 ± 0.04 and 36.48 ± 0.52% for miR-135b inhibitor group, respectively, with significantly decreased viability but increased apoptotic rate of HCT116 cells for miR-135b inhibitor group compared with that for control group and miR-135b NC group (both P < 0.05). Significantly down-regulated expressions of Bcl-2, cleaved-caspase 3, PI3K, and p-Akt and up-regulated expressions of Bax, cleaved-PARP, and PTEN were detected in miR-135b inhibitor group in comparison with those in control group and miR-135b NC group was (P < 0.05 for all).
      Conclusion   Dow-regulation of miR-135b could induce apoptosis of HCT116 cells, which might be related to the blocking of PTEN/PI3K/Akt signaling pathway.

     

/

返回文章
返回